- How Do Chemical Exposures Affect the Tumor-Immune Microenvironment?
-
Stars at Night Ballroom B4‚ Convention Center
Chair: Richard Currie, Syngenta, United Kingdom
Co-Chair: Jenna Miller, University of Michigan School of Public Health
Primary Endorser: Carcinogenesis Specialty Section
Endorser(s): Immunotoxicology Specialty Section
Endorser(s): Women in Toxicology Special Interest Group
Environmental exposures have long been known to contribute to the development of cancer. More recently, the tumor microenvironment has been recognized as playing a key role in cancer suppression or progression. Focusing on the immune system component of the tumor microenvironment, dysregulated cells and secreted molecules create a niche for neoplastic cells to evade the anti-tumor immune response and proliferate. Many carcinogens contribute to inflammation which can lead to changes in the proportions of immune cells as well as dysregulation in the production of cytokines, chemokines, and other growth factors that can alter tumor development. Investigating how specific environmental chemical exposures mechanistically reprogram the immune system addresses a key gap in our understanding of disparities in cancer prognosis. In this session, we plan to address the question: how do chemical exposures affect the tumor-immune microenvironment? The first speaker will first provide a brief overview of the tumor microenvironment, focusing on the role of the immune system and environmental chemical exposures. She will then present ongoing work on the effects of heavy metal exposures on macrophages in the context of triple negative breast cancer. The second speaker will present evidence that some environmental carcinogens promote hepatocellular cancer by creating tumor-permissive immune niches rather than by causing mutational changes. The third speaker will discuss the effect of TCDD on AhR-driven expansion and peripheral reprogramming of myeloid-derived suppressor cells that suppress anti-tumor immunity by building communication networks that can blunt T and natural killer (NK) cell function and create immune tolerance. Lastly, the fourth speaker will present about the immunotoxic effects of asbestos exposure on T and NK cells from exposed patients and those with mesothelioma, finding that an immune checkpoint inhibitor can restore NK cell function and was associated with positive response to therapy. Overall, this session will explore how environmental exposures impact immune functions within the tumor microenvironment. Modulating the tumor-immune microenvironment is a major target for new immunotherapies which makes this session both timely and of broad interest to researchers and clinicians. Understanding the effects of environmental exposures on the immune system will be critical for developing strategies for early cancer prevention, detection, and treatment.Session and Activity Type
Enter Note
Go to previous page in this tab
Event
